Based on recent deals, an effective cancer drug ag
Post# of 72435
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
I agree that if the K-OC trial is successful, CTIX should have no problem finding partners for other indications.
Quote:
Likely it will get to market for ovarian cancer first, but when CTIX secures a partnership and funding from the other drugs, they may be able to open up several other pathways for K in parallel with the ovarian cancer indication.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)